These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


236 related items for PubMed ID: 31846738

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Pathogenic insights to Parkin-linked model mice.
    Sato S, Noda S, Hattori N.
    Neurosci Res; 2020 Oct; 159():47-51. PubMed ID: 32360487
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. PARIS induced defects in mitochondrial biogenesis drive dopamine neuron loss under conditions of parkin or PINK1 deficiency.
    Pirooznia SK, Yuan C, Khan MR, Karuppagounder SS, Wang L, Xiong Y, Kang SU, Lee Y, Dawson VL, Dawson TM.
    Mol Neurodegener; 2020 Mar 05; 15(1):17. PubMed ID: 32138754
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Parkin absence accelerates microtubule aging in dopaminergic neurons.
    Cartelli D, Amadeo A, Calogero AM, Casagrande FVM, De Gregorio C, Gioria M, Kuzumaki N, Costa I, Sassone J, Ciammola A, Hattori N, Okano H, Goldwurm S, Roybon L, Pezzoli G, Cappelletti G.
    Neurobiol Aging; 2018 Jan 05; 61():66-74. PubMed ID: 29040870
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. AMP Kinase Activation is Selectively Disrupted in the Ventral Midbrain of Mice Deficient in Parkin or PINK1 Expression.
    Hang L, Thundyil J, Goh GWY, Lim KL.
    Neuromolecular Med; 2019 Mar 05; 21(1):25-32. PubMed ID: 30411223
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Aging-related motor function and dopaminergic neuronal loss in C57BL/6 mice.
    Noda S, Sato S, Fukuda T, Tada N, Hattori N.
    Mol Brain; 2020 Mar 23; 13(1):46. PubMed ID: 32293495
    [Abstract] [Full Text] [Related]

  • 13. Defects in Mitochondrial Biogenesis Drive Mitochondrial Alterations in PARKIN-Deficient Human Dopamine Neurons.
    Kumar M, Acevedo-Cintrón J, Jhaldiyal A, Wang H, Andrabi SA, Eacker S, Karuppagounder SS, Brahmachari S, Chen R, Kim H, Ko HS, Dawson VL, Dawson TM.
    Stem Cell Reports; 2020 Sep 08; 15(3):629-645. PubMed ID: 32795422
    [Abstract] [Full Text] [Related]

  • 14. Parkin cooperates with GDNF/RET signaling to prevent dopaminergic neuron degeneration.
    Meka DP, Müller-Rischart AK, Nidadavolu P, Mohammadi B, Motori E, Ponna SK, Aboutalebi H, Bassal M, Annamneedi A, Finckh B, Miesbauer M, Rotermund N, Lohr C, Tatzelt J, Winklhofer KF, Kramer ER.
    J Clin Invest; 2015 May 08; 125(5):1873-85. PubMed ID: 25822020
    [Abstract] [Full Text] [Related]

  • 15. Diverse Functions of Parkin in Midbrain Dopaminergic Neurons.
    Song P, Krainc D.
    Mov Disord; 2024 Aug 08; 39(8):1282-1288. PubMed ID: 38858837
    [Abstract] [Full Text] [Related]

  • 16. Role of Parkin and endurance training on mitochondrial turnover in skeletal muscle.
    Chen CCW, Erlich AT, Hood DA.
    Skelet Muscle; 2018 Mar 17; 8(1):10. PubMed ID: 29549884
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.